← Eichor
Study identifier: NCT05306509 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology

Condition: Solid Tumor · Hematological Malignancies  ·  Sponsor: Children's Hospital of Fudan University

PhaseNA
Planned participants120
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

This study aims to develop and implement a pediatric palliative care (PPC) program. It is an open-label, randomized trial (2:1 randomization) in pediatric oncology department of Children's Hospital of Fudan University. The intervention group will receive Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology (NiCE). The control group will receive routine PPC (will be scheduled to meet with the PPC team only when participants themselves, their families, or the attending oncologist requested an appointment). The intervention will take 6 months.

This description comes directly from the study's public registry record.

Talk to the study team

Lei Cheng, PhD  ·  +8602164161784  ·  chenglei@fudan.edu.cn

Xiaowen Zhai, MD  ·  +8602164931123  ·  zhaixiaowendy@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hemotology/Oncology Unit and Surgical Oncology Unit of Children's Hospital of Fudan UniversityShanghai, Minhang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05306509